论文信息 - 558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study - 字舞流文

558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study

N. Agarwal | M. Hurwitz | B. Tran | S. Pal | V. Karsten | A. Sacher | N. Tannir | S. Srour | E. Budde | S. Klobuch | Anjali Sharma | A. Ma | J. Haanen | Sagar Patel | E. Gurary | H. Dar | Mary-Lee Dequeant | Simon J Harrison | Kaitlyn Cohen